Teva Pharmaceutical Industries Limited (TEVA) News Headlines

▮ More

Date

Headline

5/25/2022 10:12:08 AM Teva Pharma Recalls One Lot Of Anagrelide Capsules

5/25/2022 9:48:29 AM Teva Pharmaceuticals Settles Opioid-related Claims By West Virginia

5/25/2022 9:40:52 AM Teva Reaches Agreement With West Virginia To Settle Opioid-Related Claims

5/23/2022 8:27:06 AM Teva: Study Finds Austedo Provided Improvements In TD-related Movements In Postmenopausal Women

5/23/2022 8:05:33 AM Teva : Analysis Finds AUSTEDO Provided Improvements In TD-related Movements In Postmenopausal Women

5/17/2022 9:28:23 AM Teva To Bring First Biosimilar For Lucentis In The UK - Quick Facts

5/17/2022 9:13:55 AM United Kingdom Grants License For Teva's Ophthalmology Biosimilar Ongavia

5/17/2022 8:34:09 AM Teva: New Data Highlights Potential Of ProAir Digihaler To Help Inform Treatment Decisions

5/17/2022 7:50:41 AM Teva Says New Findings Shows Potential Of ProAir Digihaler Inhalation Powder To Address Asthma Treatment Challenges

5/3/2022 7:24:00 AM Teva Pharma Trims FY22 Revenue Outlook - Update

5/3/2022 7:16:21 AM Teva Pharmaceutical Industries Limited (TEVA) Has Lowered Its FY22 Revenue Estimate To $15.4 - $16.0 Bln From $15.6 - $16.2 Bln

5/3/2022 7:15:22 AM Teva Pharmaceutical Industries Limited Q1 Earnings Summary

5/3/2022 7:03:26 AM Teva Pharma Q1 GAAP Loss Per Share $0.86; Non-GAAP EPS $0.55

5/3/2022 7:00:19 AM Teva Pharmaceutical Industries Q1 22 Earnings Conference Call At 8:00 AM ET

5/2/2022 8:37:21 AM Teva Announces Settlement With Lupin On Patent Dispute Covering AUSTEDO

5/2/2022 8:04:28 AM Teva Reaches Settlement With Lupin Resolving AUSTEDO Patent Dispute

4/19/2022 10:31:04 PM Teva Receives Complete Response Letter For TV-46000/mdc-IRM For Schizophrenia Treatment

4/5/2022 7:36:38 AM Teva Canada Launches Series Of Five Podcasts; New Initiatives Planned To Spark Dialogue On Future Healthcare Delivery

3/30/2022 9:29:45 AM Teva Reaches Settlement With Florida State To Resolve Opioid-Related Claims

3/30/2022 9:15:41 AM Teva Reaches Deal With Florida To Settle State's Opioid-Related Claims